Ahead of Earnings: Tilray Brands, Accolade, and AngioDynamics in the Spotlight
- September 30th, 2023
- 393 views
Some of the companies expected to report financial results on Wednesday, October 4, are:
Tilray Brands, Inc. (Nasdaq: TLRY), a company in the cannabis industry, is scheduled to release its first-quarter fiscal 2024 financial results before the market opens.
Analysts are forecasting a loss of $0.05 per share on revenue of $174 million.
On Friday, $TLRY closed at $2.39, up $0.04 (+1.70%).
Accolade, Inc. (Nasdaq: ACCD), a provider of personalized healthcare solutions, will unveil its fiscal second-quarter 2024 financial results after the market closes.
The consensus estimate points to a loss of $0.54 per share, accompanied by revenue reaching $94.09 million.
$ACCD closed at $10.58 on Friday, reflecting a decrease of $0.18 (-1.67%).
AngioDynamics, Inc. (Nasdaq: ANGO), a medical device company, is set to report financial results for the first quarter of fiscal year 2024 before the market opens.
Analysts expect a loss of $0.13 per share on revenue of $77.69 million.
On Friday, $ANGO closed at $7.31, down $0.01 (-0.14%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Micron Technology, Jabil, and Birkenstock Earnings Preview: What to Expect
December 15th, 2024Upcoming Earnings: Synopsys, AeroVironment, and nCino in Focus
December 01st, 2024Countdown to Earnings: Salesforce, Marvell Technology, and Okta Take the Stage
December 01st, 2024Fluence Energy, Agilent Technologies, and Woodward Earnings On Deck: A Preview
November 24th, 2024Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024
Member Login